47 transactions by 18 insiders, from April 16, 2026 to July 6, 2026.
People inside the company. What they do with their own shares is the reason this data exists.
| Insider | Trades | Planned | Bought | Sold |
|---|---|---|---|---|
| Adam KoppelDir | 6 | — | $25.0M | — |
| Andrew T. KaplanDir | 4 | — | $134.4M | — |
| Ronald C. Renaud Jr.CEO | 4 | — | — | — |
| Scott M. WassermanCMO | 2 | — | — | — |
| Douglas W. PaganCFO | 2 | — | — | — |
| Paul D. BurgessOfficer | 2 | — | — | — |
| Paula CloghessyChief | 2 | — | — | — |
| Scott AkamineGC | 2 | — | — | — |
| Jamie Beth ColemanChief | 2 | — | — | — |
| John F. MilliganDir | 1 | — | — | — |
| Kathleen TregoningOfficer | 1 | — | — | — |
| Martin MackayDir | 1 | — | — | — |
| Frank ClyburnDir | 1 | — | — | — |
| Christopher HiteDir | 1 | — | — | — |
Holders above 10%, often funds. They file the same form, but they trade for portfolio reasons, not because of what they know.
| Insider | Trades | Planned | Bought | Sold |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC10% | 5 | — | $25.0M | — |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% | 4 | — | — | — |
| RTW INVESTMENTS, LP10% | 4 | — | $8.0M | — |
| BAIN CAPITAL INVESTORS LLC10% | 3 | — | $134.4M | — |
47 in total, newest filings first.
| Insider | Date | Code | Shares | Price | Value |
|---|---|---|---|---|---|
| Kathleen TregoningOfficerDERIV | Jul 6 | A | 175,000 | $0.00 | —? |
| Ronald C. Renaud Jr.CEODERIV | Jun 9 | M | 38,094 | $0.00 | —? |
| Ronald C. Renaud Jr.CEO | Jun 9 | M | 38,094 | $5.25 | $200K |
| RTW INVESTMENTS, LP10%DERIVJOINT | Apr 20 | C | 2,026,820 | — | — |
| RTW INVESTMENTS, LP10%DERIVJOINT | Apr 20 | C | 8,250,000 | — | — |
| RTW INVESTMENTS, LP10%JOINT | Apr 20 | P | 500,000 | $16.00 | $8.0M |
| RTW INVESTMENTS, LP10%JOINT | Apr 20 | C | 10,276,820 | — | — |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd.10%DERIV | Apr 20 | C | 708,814 | $0.00 | —? |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd.10%DERIV | Apr 20 | C | 4,968,789 | $0.00 | —? |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% | Apr 20 | C | 2,034,133 | — | — |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% | Apr 20 | C | 9,477,719 | — | — |
| Adam KoppelDirDERIV | Apr 16 | A | 38,300 | $0.00 | —? |
| Adam KoppelDirDERIV | Apr 20 | C | 4,145,768 | $0.00 | —? |
| Adam KoppelDirDERIV | Apr 20 | C | 16,875,000 | $0.00 | —? |
| Adam KoppelDir | Apr 20 | P | 1,562,500 | $16.00 | $25.0M |
| Adam KoppelDir | Apr 20 | C | 4,145,768 | — | — |
| Adam KoppelDir | Apr 20 | C | 16,875,000 | — | — |
| Andrew T. KaplanDirDERIV | Apr 16 | A | 38,300 | $0.00 | —? |
| Andrew T. KaplanDirDERIV | Apr 20 | C | 17,857,143 | $0.00 | —? |
| Andrew T. KaplanDir | Apr 20 | P | 8,398,438 | $16.00 | $134.4M |
| Andrew T. KaplanDir | Apr 20 | C | 17,857,143 | — | — |
| Ronald C. Renaud Jr.CEODERIV | Apr 16 | A | 300,000 | $0.00 | —? |
| Ronald C. Renaud Jr.CEODERIV | Apr 16 | A | 300,000 | $0.00 | —? |
| John F. MilliganDirDERIV | Apr 16 | A | 38,300 | $0.00 | —? |
| Martin MackayDirDERIV | Apr 16 | A | 38,300 | $0.00 | —? |
| Scott M. WassermanCMODERIV | Apr 16 | A | 100,000 | $0.00 | —? |
| Scott M. WassermanCMODERIV | Apr 16 | A | 100,000 | $0.00 | —? |
| Douglas W. PaganCFODERIV | Apr 16 | A | 100,000 | $0.00 | —? |
| Douglas W. PaganCFODERIV | Apr 16 | A | 100,000 | $0.00 | —? |
| Christopher HiteDirDERIV | Apr 16 | A | 38,300 | $0.00 | —? |
| Jamie Beth ColemanChiefDERIV | Apr 16 | A | 75,000 | $0.00 | —? |
| Jamie Beth ColemanChiefDERIV | Apr 16 | A | 75,000 | $0.00 | —? |
| Frank ClyburnDirDERIV | Apr 16 | A | 38,300 | $0.00 | —? |
| Paula CloghessyChiefDERIV | Apr 16 | A | 60,000 | $0.00 | —? |
| Paula CloghessyChiefDERIV | Apr 16 | A | 60,000 | $0.00 | —? |
| Paul D. BurgessOfficerDERIV | Apr 16 | A | 100,000 | $0.00 | —? |
| Paul D. BurgessOfficerDERIV | Apr 16 | A | 100,000 | $0.00 | —? |
| Bain Capital Life Sciences Investors, LLC10%DERIVJOINT | Apr 20 | C | 4,145,768 | $0.00 | —? |
| Bain Capital Life Sciences Investors, LLC10%DERIVJOINT | Apr 20 | C | 16,875,000 | $0.00 | —? |
| Bain Capital Life Sciences Investors, LLC10%JOINT | Apr 20 | P | 1,562,500 | $16.00 | $25.0M |
| Bain Capital Life Sciences Investors, LLC10%JOINT | Apr 20 | C | 4,145,768 | — | — |
| Bain Capital Life Sciences Investors, LLC10%JOINT | Apr 20 | C | 16,875,000 | — | — |
| BAIN CAPITAL INVESTORS LLC10%DERIVJOINT | Apr 20 | C | 17,857,143 | $0.00 | —? |
| BAIN CAPITAL INVESTORS LLC10%JOINT | Apr 20 | P | 8,398,438 | $16.00 | $134.4M |
| BAIN CAPITAL INVESTORS LLC10%JOINT | Apr 20 | C | 17,857,143 | — | — |
| Scott AkamineGCDERIV | Apr 16 | A | 60,000 | $0.00 | —? |
| Scott AkamineGCDERIV | Apr 16 | A | 60,000 | $0.00 | —? |